1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine as outlined in NIAID's Strategic Plan for Research to Develop a Valley fever Vaccine.
Get alerted about grants like this
Save a search for “National Institute of Allergy and Infectious Diseases (NIAID)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93. 855 -- Allergy and Infectious Diseases Research Last Updated: May 13, 2026 View version history on Grants.
gov City or township governments Special district governments Federally recognized Native American tribal governments Public and Indian housing authorities For-profit organizations other than small businesses Independent school districts Public and state institutions of higher education Private institutions of higher education Nonprofits non-higher education without 501(c)(3) Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Refer to Section III.
Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Grantor contact information National Institute of Allergy and Infectious Diseases (NIAID) CoccidioidomycosisResearchCenters@mail. nih.
gov CoccidioidomycosisResearchCenters@mail. nih. gov CoccidioidomycosisResearchCenters@mail.
nih. gov File name Description Last updated RFA-AI-27-012-Full-Announcement. html RFA-AI-27-012-Full-Announcement.
html Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed. Confirm the full requirements in the official notice before applying.
Applications for Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) are due July 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) is funded by National Institute of Allergy and Infectious Diseases (NIAID). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Research Project Grant (Parent R01 Clinical Trial Not Allowed) is a flagship NIH grant administered by the National Institute of Allergy and Infectious Diseases that funds investigator-initiated biomedical and behavioral research projects not involving clinical trials. The R01 supports hypothesis-driven research across a wide range of health topics including infectious diseases, immune disorders, and allergy-related conditions. Eligible applicants include higher education institutions such as public and private universities. Award amounts range from $250,000 to $2,500,000 with a deadline of June 5, 2026.
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID) - NIH. The TRACs program aims to develop the next generation of TB researchers and catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.